Resubmission of the supplemental biologics license application provided more data on improvement in hives and itching in ...

The FDA approved dupilumab (Dupixent) for chronic spontaneous urticaria (CSU) in patients 12 years and older, the first new ...

The first step in managing hives is to find out the cause ... use it as directed even if you're unsure whether your symptoms are allergy-related. It’s safe to use. Call 911 or get emergency ...

The following is a summary of “Dupilumab Improves Dermatology-Specific Quality of Life in Patients with Chronic Spontaneous ...

Allergy shots work well after the first year for inhaled allergens like pollen, trees, grasses, and molds. Another treatment that gives you a bit of the allergen is available in tablets or drops ...

Significant advances in treatment for chronic spontaneous urticaria (CSU), hereditary angioedema (HAE), and anaphylaxis were presented at the American Academy of Allergy, Asthma and Immunology ...

Angioedema most often affects the lips, eyes, tongue, throat, arms, and legs. It is the swelling of the lower layer of tissue just under the skin or mucous membranes, where fluid builds and ...

Patients with hereditary angioedema who switched from other drugs to donidalorsen for long-term prophylaxis experienced fewer ...

The FDA approved dupilumab for the treatment of patients 12 years and older with chronic spontaneous urticaria who remain ...